Penicillin and Macrolide Resistance in Pneumococcal Pneumonia: Does In Vitro Resistance Affect Clinical Outcomes?

Rothermel, Constance D.
May 2004
Clinical Infectious Diseases;5/15/2004 Supplement, Vol. 38, pS346
Academic Journal
In vitro resistance to antimicrobial agents is escalating among pathogens responsible for the most serious respiratory tract infections. Some reports have suggested that this has direct clinical implications. Because of penicillin and macrolide resistance in Streptococcus pneumoniae, current guidelines for the initial treatment of respiratory tract infections advocate less reliance on the use of either of these classes of drugs in single- agent therapy. Recent studies that have assessed the impact of β-lactam and macrolide resistance on clinical outcomes in community-acquired pneumonia fall to provide incontrovertible evidence for a direct link between in vitro resistance and treatment failure. However, there are anecdotal reports of breakthrough bacteremia due to macrolide-resistant pneumococci among patients receiving macrolide therapy, unlike the situation for β-lactams and penicillin-resistant pneumococci. Continued efforts, including in vitro surveillance, appropriate antibiotic use campaigns, and immunization programs, will be important in limiting the spread of drug- resistant S. pneumoniae.


Related Articles

  • Clonal and Capsular Types Decide Whether Pneumococci Will Act as a Primary or Opportunistic Pathogen. Sjöström, K.; Spindler, C.; Ortqvist, A.; Kalin, M.; Sandgren, A.; Kühlmann-Berenzon, S.; Henriques-Normark, B. // Clinical Infectious Diseases;2/15/2006, Vol. 42 Issue 4, p451 

    Background. Streptococcus pneumoniae is a major cause of morbidity and mortality worldwide. The role of the different capsular and clonal types in invasive disease severity remains to be defined. Methods. Disease severity and disease type were correlated to age, underlying disease, capsular...

  • Role of beta-lactam agents in the treatment of community-acquired pneumonia. Garau, J. // European Journal of Clinical Microbiology & Infectious Diseases;Feb2005, Vol. 24 Issue 2, p83 

    Community-acquired pneumonia (CAP) is a common illness associated with high rates of morbidity and mortality worldwide. The ß-lactam antibacterial agents have been the mainstay of therapy for CAP for over four decades and remain as first-line therapy. However, the impact of the substantial...

  • Nationwide survey of the development of drug-resistant pathogens in the pediatric field: drug sensitivity of Streptococcus pneumoniae in Japan. Yoshitake Sato; Yoshikiyo Toyonaga; Hideaki Hanaki; Masato Nonoyama; Tomohiro Oishi; Keisuke Sunakawa // Journal of Infection & Chemotherapy (Springer Science & Business;Dec2009, Vol. 15 Issue 6, p396 

    Abstract  We evaluated the resistance to 20 different antibacterial agents of 362 clinically isolated strains of Streptococcus pneumoniae accumulated from October 2000 to July 2001 (phase 1) and of 332 different strains accumulated from January to June 2004 (phase 2), from institutions...

  • Lobar pneumonia treated by Musgrave Park physicians. Hedley-Whyte, John; Milamed, Debra R. // Ulster Medical Journal;2009, Vol. 78 Issue 2, p119 

    In the decade 1935-45 the treatment of lobar pneumonia in the developed and warring world underwent a series of evolutions--anti-sera, specific anti-sera, refinement of sulpha drugs, sulpha and anti-sera, the introduction of penicillin for bacteriology, then ophthalmology, and then for...

  • Clinical Outcomes of Pneumococcal Pneumonia Caused by Antibiotic-Resistant Strains in Asian Countries: A Study by the Asian Network for Surveillance of Resistant Pathogens. Jae-Hoon Song; Jung, Sook-In; Kyun Ki, Hyun; Myung-Hee Shin; Ko, KwanSoo; Son, Jun Seong; Chang, Hyun- Ha; Kim, Shin Woo; Lee, Hyuck; Kim, Yeon-Sook; Oh, Won Sup; Peck, Kyong Ran; Chongthaleong, Anan; Lalitha, M. K.; Perera, Jennifer; Yee, Ti Teow; Jamal, Farida; Kamarulzaman, Adeeba; Carlos, Celia C.; So, Thomas // Clinical Infectious Diseases;6/1/2004, Vol. 38 Issue 11, p1570 

    To evaluate the clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries, we performed a prospective observational study of 233 cases of adult pneumococcal pneumonia in 9 Asian countries from January 2000 to June 2001. Among 233 isolates, 128 (55%)...

  • Incidence and Severity of Invasive Streptococcus pneumoniae, Group A Streptococcus, and Group B Streptococcus Infections Among Pregnant and Postpartum Women. Deutscher, Meredith; Lewis, Melissa; Zell, Elizabeth R.; Taylor Jr., Thomas H.; Van Beneden, Chris; Schrag, Stephanie // Clinical Infectious Diseases;7/15/2011, Vol. 53 Issue 2, p114 

    Background. The epidemiology of streptococcal infection in pregnant and postpartum women is poorly described in recent literature. We used data from multistate surveillance for invasive Streptococcus pneumoniae, group A Streptococcus (GAS), and group B Streptococcus (GBS) infections to estimate...

  • FDA adjusts breakpoints for treatment of S. pneumoniae with penicillin G potassium injection. Block, Stan // Infectious Diseases in Children;May2008, Vol. 21 Issue 5, p5 

    The article reports on the decision of the U.S. Food and Drug Administration (FDA) to change the breakpoints for the treatment of pneumococcal pneumonia with penicillin G potassium injection. The change in breakpoints was made by the FDA in response to findings that pneumococcal pneumonia...

  • PNEUMOCOCCIC SEGMENTAL (LOBAR) PNEUMONIA. Townsend Jr., Edward H.; Decancq Jr., H. George // Clinical Pediatrics;Feb1965, Vol. 4 Issue 2, p117 

    The article summarizes six years' experience with lobar pneumonia as encountered in the home, hospital and office. It emphasizes that a single injection of procaine penicillin-G is as efficacious in the treatment of lobar pneumonia due to Diplococcus pneumoniae as are therapeutic programs...

  • Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis. Sethi, Sanjay; Anzueto, Antonio; Farrell, David J // Annals of Clinical Microbiology & Antimicrobials;2005, Vol. 4, p5 

    Background: Antimicrobial therapy is considered an important component in the medical management of most patients with acute exacerbation of chronic bronchitis (AECB). The three predominant bacterial species isolated are nontypeable Haemophilus influenzae, Moraxella catarrhalis, and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics